InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
47.00
+2.10 (4.68%)
At close: Jan 9, 2026

HKG:3696 Revenue

InSilico Medicine Cayman TopCo had revenue of $27.46M USD in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to $53.60M. In the year 2024, InSilico Medicine Cayman TopCo had annual revenue of $85.83M with 67.71% growth.

Revenue (ttm)
$53.60M
Revenue Growth
+67.71%
P/S Ratio
62.08
Revenue / Employee
$168.03K
Employees
319
Market Cap
26.12B HKD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202485.83M34.65M67.71%
Dec 31, 202351.18M21.03M69.77%
Dec 31, 202230.15M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition